Contrast Sensitivity in Glaucoma

Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00947869

Enrollment

Registered

2009-07-28

Start date

2009-04-30

Completion date

Unknown

Last updated

2009-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Open Angle Glaucoma, Secondary Open Angle Glaucoma Due to PEX

Brief summary

The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring contrast sensitivity. No therapeutic studies are performed.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients: Primary open angle glaucoma, secondary open angle glaucoma due to PEX * Healthy volunteers (for reliability analysis) Inclusion Criteria: * Age \> 18 * Best corrected visual acuity 0.8 or better * European

Exclusion criteria

* eye diseases: Infantile glaucoma, angle glaucoma, secondary open angle glaucoma, wich are not due to PEX, diseases involving retina, condition after ophthalmological operations or trauma, cataract, diseases concerning the refractive system, age-related macular degeneration, diabetic retinopathy, optic neuropathy (MS, neuritis), amblyopia * Any neurological diseases * Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus) * Systemic drugs with potentially ocular involvement * ocular drugs

Countries

Germany

Contacts

Primary ContactAnselm G Juenemann, Prof.

anselm.juenemann@uk-erlangen.de

Outcome results